calendar
1,767 catalysts · 3,350 8k filing · 2,283 grant · 1,767 approval · 1,155 device 510k · 1,000 device adverse event · 833 device pma
1,767 catalysts · 3,350 8k filing · 2,283 grant · 1,767 approval · 1,155 device 510k · 1,000 device adverse event · 833 device pma
no tagged catalysts yet
Sponsor: RISING. Form: TABLET. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: POWDER. Route: IV (INFUSION)
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: GRANULES. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: CHARTWELL. Form: SOLUTION. Route: ORAL
Sponsor: PH HEALTH. Form: SOLUTION. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: TELIX. Form: POWDER. Route: INTRAVENOUS
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: SHREE HARI INTL. Form: SYRUP. Route: ORAL
Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL
Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: TEVA PHARMS USA INC. Form: INSERT. Route: VAGINAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS
Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS